The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and Viscum album L. Treatment
Table 1
Baseline characteristics of primary breast cancer patients (n = 64) at day of first diagnosis.
Total
CTX
CTX+VA
VA
p-value
Number of patients, n ()
64 (100)
25 (100)
31 (100)
8 (100)
Age, years, median (IQR)
54.8 (46.3-65.3)
50.5 (44.0-52.0)
56.9 (49.9-65.3)
59.9 (51.0-76.2)
0.155
BMI, median (IQR)
25.9 (22.7-28.0)
26.3 (23.0-28.8)
25.3 (22.2-28.2)
26.8 (23.0-27.4)
0.231
UICC stages, n ()
I
24 (37.5)
9 (36.0)
13 (41.9)
2 (25.0)
II
26 (40.6)
10 (40.0)
12 (38.7)
4 (50.0)
0.926
III
14 (21.9)
6 (24.0)
6 (19.4)
2 (25.0)
Hormonal status, n ()
Pre-menopausal
26 (40.6)
15 (60.0)
8 (25.8)
3 (37.5)
Peri-menopausal
5 (7.8)
4 (16.0)
1 (3.2)
0 (0)
0.008
Post-menopausal
33 (51.6)
6 (24.0)
22 (71.0)
5 (62.5)
Estrogen receptor positive
41 (64.1)
15 (60.0)
19 (61.3)
7 (87.5)
0.334
Progesteron receptor positive
40 (62.5)
16 (64.0)
19 (61.3)
5 (62.5)
0.979
HER 2 positive
23 (35.9)
7 (28.0)
14 (45.2)
2 (25.5)
0.325
Interventions, n ()
CTX, n (%)
56 (87.5)
25 (100)
31 (100)
0 (0)
<0.001
VA therapy, n (%)
39 (60.9)
0 (0)
31 (100)
8 (100)
<0.001
Radiation, n (%)
44 (68.8)
19 (76)
22 (88.0)
3 (37.5)
0.115
TNM staging according to the Union for International Cancer Control (UICC). n = number of patients and portion (%). CTX = chemotherapy; VA = Viscum album L. therapy; BMI: body mass index. The p-values of Pearson’s chi-square analyses of the three groups were determined using R-statistics.
